Lymphoma Clinical Trial
Official title:
Image-guided Lymphadanectomy in AMIGO
To perform image-guided laparoscopic intra-abdominal lymph node biopsy with goal of minimizing surgical risk and improving accuracy of biopsy.
Only the superficial lymph nodes are accessible to physical examination, and assessment of
deeper nodes, such as those in the abdomen, requires radiological imaging. As a result,
abdominal CT and PET scanning of patients with a history of malignancy or concerns for a new
diagnosis of cancer is an important diagnostic test. As well as looking for distant
metastasis, the images are carefully assessed for evidence of intra-abdominal
lymphadenopathy, which can be a marker of new or recurrent cancer. If such nodes are
identified, they often require a biopsy for further evaluation.
The lymph nodes located in the abdomen or the retroperitoneum are not easily accessible for
percutaneous biopsy, often requiring an abdominal exploration which can be done either
laparoscopically or via laparotomy. The laparoscopic approach represents a better approach
that is associated with reduced surgical risks and complications as well as a quicker
recover. In fact in many cases, the laparoscopic approach can be done as a day surgery
procedure.
Although non-invasive imaging technologies such as computed tomography (CT) scanning,
magnetic resonance imaging (MRI), and positron emission tomography (PET) scanning can be
useful in the diagnosis of lymphadenopathy, they often provide an estimate of the location of
the nodes, and exact localization of the lymph node of interest can be challenging. The
surgeons rely on anatomical landmarks which can be distorted during laparoscopy and to help
reduce the rate of false negative lymph node biopsy, the surgeons often perform
intra-operative histological assessment of the lymph nodes (Frozen Section) which can be time
consuming and in itself associated with diagnostic errors. The uncertainty about the exact
location of the node of interest often leads to extensive surgical dissection, biopsy of
multiple nodes, and sometimes repeat surgery. During the dissection, care must be taken to
avoid injury to the neighboring structures, such as blood vessels, nerves or adjacent organs.
In cases, where an intra-operative dissection occurs, or lymph nodes can not be identified,
the laparoscopic surgery is converted to open surgery.
Using the unique capabilities of the AMIGO suite, investigators aim to test intra-operative
image guidance to help them identify diseased intra-abdominal lymph nodes, allowing for more
precise and safer surgeries. The improved accuracy will allow investigators to perform
surgeries with minimal dissection and reduced complications while improving biopsy rates and
enhancing ability to accurately stage intra-abdominal malignancies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540340 -
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
|
Phase 1 | |
Completed |
NCT01947140 -
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
|
Phase 1/Phase 2 | |
Completed |
NCT00001512 -
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
|
Phase 1 | |
Recruiting |
NCT05618041 -
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
|
N/A | |
Completed |
NCT01410630 -
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
|
||
Active, not recruiting |
NCT04270266 -
Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
|
N/A | |
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT01949883 -
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
|
Phase 1 | |
Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
Recruiting |
NCT04904588 -
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
|
Phase 2 | |
Recruiting |
NCT05019976 -
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
|
N/A | |
Completed |
NCT04434937 -
Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)
|
Phase 2 | |
Completed |
NCT01855750 -
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
|
Phase 3 | |
Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT00775268 -
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
Active, not recruiting |
NCT03936465 -
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
|
Phase 1 |